Chiral SPE: Revolutionary New Product Enables Chemists to Do the Previously Impossible; Now Chemists Can Get Chiral Enrichment with the Speed of SPE

BIOWIRE2K
SAN FRANCISCO--(BUSINESS WIRE)--Sept. 13, 2006--Evolved Nanomaterial Sciences (ENS), a Cambridge-based company that uses patented nanotechnology to revolutionize the chiral drug development process, announced today the release of ENS Chiral Solid Phase Extraction (SPE) cartridges that will allow chemists to enrich in minutes what currently takes hours using traditional methods. Initially, the Chiral SPE will be available in 1, 3, 6 mL cartridges and wellplates.

"With ENS Chiral SPE, chemists can now do the previously impossible - enrich enantiomeric mixtures in minutes without costly apparatus or lengthy method development times. It is as easy as...dissolve and extract," said ENS CEO Robert Pucciariello. "Chiral SPE is a truly revolutionary product, with the potential to open up new horizons and speed up critical processes for chemists in a variety of industries."

“Chiral SPE is a truly revolutionary product, with the potential to open up new horizons and speed up critical processes for chemists in a variety of industries.”

Certain pharmaceutically import molecules are made up of mirror-image molecules called enantiomers that have to be separated from each other. ENS Chiral SPE extracts one enantiomer while allowing the second to flow through, by utilizing a patented nanotechnology to provide a shape-based solution to a shape-based problem. Thus, ENS Chiral SPE is effective with a broad range of chiral compounds, allows standalone chiral sample preparation or enrichment under a wide range of conditions. Importantly, the technology scales from research to manufacture.

ENS' Chiral SPE and the patented nanotechnology behind it - as well as the new ENS Analytical NP Chiral Column -- is being exhibited at American Chemical Society 232nd Fall Exposition at the San Francisco Moscone Center this week.

About Evolved Nanomaterial Sciences (ENS)

Headquartered in Cambridge, MA, ENS utilizes patented nanotechnology to enable previously unattainable molecular separations, offering unprecedented selectivity -- dramatically simplifying and speeding up the drug discovery and scale-up process. ENS' web site is www.ensnano.com.

Contacts

Evolved Nanomaterial Sciences
Gail Cowan, 773-782-3909

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.